Olverembatinib for heavily pretreated BCR::ABL1-positive leukemia, including resistance or intolerance to ponatinib and/or asciminib

Olverembatinib 用于治疗既往接受过大量治疗的 BCR::ABL1 阳性白血病，包括对 ponatinib 和/或 asciminib 耐药或不耐受的情况。